• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Numerate, Inc

edit

Numerate is working to build and validate a drug engineering process to deliver leads more quickly, more reliably, and at less cost.

Recent Milestones

edit

• 
  Numerate, Inc received $5.5M in Series B funding. (3/1/09)
  Posted 4/13/09 at 3:30pm via venturebeat.com
• 
  Numerate, Inc added John Griffin as Chief Scientific Officer.
  Posted 3/4/13 at 5:08am
• 
  Numerate, Inc added Guido Lanza as Chief Executive Officer.
  Posted 3/4/13 at 5:08am
• 
  Numerate, Inc added Brandon Allgood as Chief Technology Officer.
  Posted 5/3/13 at 8:22am

Videos

Screenshots

edit

Sources

1. Numerate racks up $5.5M for drug engineering technology (venturebeat.com) [edit]